2019 Cancer Communications Committee
All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Name Employment Leadership Stock and Other Honoraria Consulting or Advisory Speakers' Bureau Research Funding Patents, Royalties, Other Expert Testimony Travel, Other Relationship Ownership Interests Role Intellectual Property Accommodations, Expenses
Neeraj Agarwal AstraZeneca Active Biotech (Inst) Bayer Amgen (Inst) Bristol-Myers Squibb AstraZeneca (Inst) Clovis Oncology Bavarian Nordic (Inst) Eisai Bayer (Inst) EMD Serono BN ImmunoTherapeutics Exelixis (Inst) Foundation One Inc Bristol-Myers Squibb (Inst) Genentech/Roche Calithera Biosciences Lilly (Inst) Medivation/Astellas Celldex (Inst) Merck Eisai (Inst) Nektar Exelixis (Inst) Novartis Genentech (Inst) Pfizer GlaxoSmithKline (Inst) Pharmacyclics Immunomedics (Inst) Janssen (Inst) Merck (Inst) Newlink Genetics (Inst) Novartis (Inst) Pfizer (Inst) Prometheus (Inst) Rexahn Pharmaceuticals (Inst) Sanofi (Inst) Takeda (Inst) TRACON Pharma (Inst)
Suzanne Cole Research to Practice William Dale Robert Dreicer Astellas Pharma BioClin Therapeutics (Inst) AstraZeneca Genentech (Inst) Eisai Janssen Oncology (Inst) EMD Serono Merck (Inst) Genentech/Roche Seattle Genetics (Inst) Incyte Janssen Oncology Pfizer David L. Graham Medscape Biopep Solution John Heymach Bio-Tree AstraZeneca AstraZeneca (Inst) #Licensing agreement Cardinal Spine Boehringer Ingelheim Bayer between Spectrum and Bristol-Myers Squibb GlaxoSmithKline MD Anderson (including EMD Serono Spectrum myself) regarding Genentech Pharmaceuticals intellectual property for GlaxoSmithKline treatment of EGFR and Guardant Health HER2 exon 20 mutations Hengrui Pharmaceutical Lilly Merck Novartis Spectrum Pharmaceuticals Syntha Pharmaceutical
Joshua A. Jones Randall J. Kimple Galera Therapeutics Ascension Ventures Igynta #Patent licensed through International Journal of Peloton Therapeutics the Univ of North Radiation Oncology Threshold Carolina. (I) Biology and Physics Pharmaceuticals
#Patent licensed through the Wisconsin Alumni Research Fund (I)
Name Employment Leadership Stock and Other Honoraria Consulting or Advisory Speakers' Bureau Research Funding Patents, Royalties, Other Expert Testimony Travel, Other Relationship Ownership Interests Role Intellectual Property Accommodations, Expenses Catherine S. Magid Diefenbach Gilead Sciences Bayer Bristol-Myers Squibb (Inst) #Roche (Inst) Bristol-Myers Squibb Genentech (Inst) Genentech/Roche Incyte (Inst) Janssen Janssen (Inst) Merck LAM Therapeutics (Inst) Seattle Genetics MEI Pharma (Inst) Merck (Inst) Millennium (Inst) Roche/Genentech (Inst) Seattle Genetics (Inst)
Merry J. Markham Aduro Biotech (Inst) Lilly (Inst) Tesaro (Inst) Sumanta K. Pal Astellas Pharma Astellas Pharma Medivation Medivation Aveo Novartis Bristol-Myers Squibb Eisai Exelixis Genentech Ipsen Myriad Pharmaceuticals Novartis Pfizer
Blase N. Polite Merck Tapestry Pharmaceuticals Gerson Lehrman Group
Carlos Rodriguez-Galindo Novimmune Michael S. Sabel #Breast Cancer Ally and Melanoma Ally mobile technologies. Richard L. Schilsky AstraZeneca (Inst) Varian Bayer (Inst) Bristol-Myers Squibb (Inst) Genentech/Roche (Inst) Lilly (Inst) Merck (Inst) Pfizer (Inst)
Mario Sznol Actym Therapeutics Abbvie AcademicCME Adaptive Biotechnologies Adaptimmune Clinical Care Options Amphivena Allakos DAVAOncology Intensity Therapeutics Almac Diagnostics Haymarket Media Torque Anaeropharma Imedex Anaeropharma Physician Education Array BioPharma Resource AstraZeneca/MedImmune Prime Oncology Biodesix Research to Practice Bristol-Myers Squibb TRM Oncology Celldex Vindico Chugai/Roche Genentech/Roche Genmab Genocea Biosciences GI Innovation Gritstone Oncology Hinge immunocore Incyte Innate Pharma Inovio Pharmaceuticals Kyowa Hakko Kirin Lilly Merck Sharp & Dohme Modulate Molecular Partners Nektar Newlink Genetics Novartis Omniox Pieris Pharmaceuticals Pierre Fabre Seattle Genetics Symphogen Robert Uzzo Genentech/Roche Janssen Oncology Novartis Johnson & Johnson Pfizer Name Employment Leadership Stock and Other Honoraria Consulting or Advisory Speakers' Bureau Research Funding Patents, Royalties, Other Expert Testimony Travel, Other Relationship Ownership Interests Role Intellectual Property Accommodations, Expenses Shannon N. Westin AstraZeneca ArQule BioAscent AstraZeneca Casdin Capital Bayer Clovis Oncology Celgene (I) Genentech Gerson Lehrman Group Medivation Medscape Merck Ovation Sciences Pfizer Roche Clovis Oncology Tesaro Cotinga Pharmaceuticals Vaniam Group Critical Outcome Vermillion Technologies Watermark Research Karyopharm Therapeutics Partners (I)
Kite Pharma (I)
Novartis Roche/Genentech Tesaro